ATE556084T1 - Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c - Google Patents
Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis cInfo
- Publication number
- ATE556084T1 ATE556084T1 AT08000552T AT08000552T ATE556084T1 AT E556084 T1 ATE556084 T1 AT E556084T1 AT 08000552 T AT08000552 T AT 08000552T AT 08000552 T AT08000552 T AT 08000552T AT E556084 T1 ATE556084 T1 AT E556084T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- hepatitis
- characterizing
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36360302P | 2002-03-11 | 2002-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE556084T1 true ATE556084T1 (de) | 2012-05-15 |
Family
ID=28041784
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08000552T ATE556084T1 (de) | 2002-03-11 | 2003-03-11 | Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c |
AT08014584T ATE469162T1 (de) | 2002-03-11 | 2003-03-11 | Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c |
AT03714097T ATE423785T1 (de) | 2002-03-11 | 2003-03-11 | Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08014584T ATE469162T1 (de) | 2002-03-11 | 2003-03-11 | Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c |
AT03714097T ATE423785T1 (de) | 2002-03-11 | 2003-03-11 | Verfahren und zusammensetzungen zur identifikation und charakterisierung von hepatitis c |
Country Status (9)
Country | Link |
---|---|
US (3) | US20070172926A1 (de) |
EP (3) | EP1490383B1 (de) |
AT (3) | ATE556084T1 (de) |
AU (2) | AU2003218111B8 (de) |
DE (2) | DE60326327D1 (de) |
DK (3) | DK1490383T3 (de) |
ES (3) | ES2386742T3 (de) |
PT (3) | PT2014671E (de) |
WO (1) | WO2003077729A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2386742T3 (es) | 2002-03-11 | 2012-08-28 | Lab 21 Limited | Método y composiciones para identificar y caracterizar la Hepatitis C |
CA2604442A1 (en) * | 2005-04-11 | 2006-10-19 | Mingjun Huang | Pharmaceutical compositions for and methods of inhibiting hcv replication |
WO2007042827A2 (en) * | 2005-10-14 | 2007-04-19 | Ivan Petyaev | Treatment and diagnosis of obligate intracellular pathogens |
CN100365124C (zh) * | 2005-10-27 | 2008-01-30 | 云南大学 | 一段丙型肝炎病毒特异性cDNA序列的应用 |
US20090082344A1 (en) * | 2006-07-13 | 2009-03-26 | Searete Llc | Methods and systems for treating disease |
US20080015834A1 (en) * | 2006-07-13 | 2008-01-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for molecular inhibition |
US20080014572A1 (en) * | 2006-07-13 | 2008-01-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for molecular inhibition |
EP2121991A2 (de) * | 2006-10-20 | 2009-11-25 | Innogenetics N.V. | Methodik zur analyse von sequenzvariationen innerhalb des hcv-ns3/4a-genombereichs |
EP2463389A1 (de) | 2006-10-20 | 2012-06-13 | Innogenetics N.V. | Methodik zur Analyse von Sequenzvariationen innerhalb des HCV-NS5B-Genombereichs |
RU2010121770A (ru) * | 2007-10-30 | 2011-12-10 | Интермьюн, Инк. (Us) | Генотипирование и фенотипирование hcv |
JP5607532B2 (ja) * | 2007-10-31 | 2014-10-15 | デバイオファーム エスエイ | Hcv薬剤抵抗性のほぼ全ゲノムのアッセイ |
EP2576823A1 (de) | 2010-06-04 | 2013-04-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Konstitutiv aktive prolactin-rezeptorvarianten als prognostische marker und therapeutische ziele zur vorbeugung des fortschritts von hormonabhängigen karzinomen in richtung hormonunabhängigkeit |
US9528163B2 (en) | 2011-06-20 | 2016-12-27 | Siemens Healthcare Diagnostics Inc. | Reagents and methods for detecting HCV |
AU2013205064B2 (en) * | 2012-06-04 | 2015-07-30 | Gen-Probe Incorporated | Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
DE318216T1 (de) | 1987-11-18 | 1990-06-13 | Chiron Corp., Emeryville, Calif., Us | Nanbv-diagnostika und vakzine. |
US5350671A (en) | 1987-11-18 | 1994-09-27 | Chiron Corporation | HCV immunoassays employing C domain antigens |
US5372928A (en) * | 1989-09-15 | 1994-12-13 | Chiron Corporation | Hepatitis C virus isolates |
EP0435229A1 (de) * | 1989-12-27 | 1991-07-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | DNS-Gen von einem Non-A Non-B Hepatitis-Virus, seine Klonierung und Verwendung |
US5747339A (en) * | 1990-06-25 | 1998-05-05 | Research Foundation For Microbial Diseases Of Osaka | Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide |
HU227547B1 (en) * | 1991-06-24 | 2011-08-29 | Novartis Vaccines & Diagnostic | Hepatitis c virus (hcv) polypeptides |
US20030125270A1 (en) * | 2000-12-18 | 2003-07-03 | Lawrence Blatt | Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection |
BR9405334A (pt) * | 1993-04-27 | 1999-05-25 | Innogenetics Nv | Novas sequências de genótipos de vírus da hepatite c e seu uso como agentes terapêuticos e diagnóstico |
ES2231773T3 (es) * | 1993-05-05 | 2005-05-16 | Common Services Agency | Virus de la hepatitis c de tipo 4, 5 y 6. |
US5571673A (en) * | 1994-11-23 | 1996-11-05 | Hoffmann-La Roche Inc. | Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US6242187B1 (en) * | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US7338759B1 (en) * | 1997-03-04 | 2008-03-04 | Washington University | HCV variants |
US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
JP2001512036A (ja) * | 1997-07-30 | 2001-08-21 | バイアラジック・インコーポレーテッド | 抗ウイルス薬剤感受性および耐性を測定するための組成物および方法、並びに抗ウイルス薬剤をスクリーニングするための組成物および方法 |
US6280940B1 (en) * | 1998-08-05 | 2001-08-28 | Agouron Pharmaceuticals, Inc. | Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
WO2001079540A2 (en) * | 2000-04-18 | 2001-10-25 | Virco Bvba | Methods for measuring drug resistance |
ES2373642T3 (es) * | 2000-05-23 | 2012-02-07 | Washington University | Variantes de vhc. |
US20040137424A1 (en) * | 2000-07-24 | 2004-07-15 | Tan Yin Hwee | Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates |
US6680059B2 (en) * | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
ES2386742T3 (es) | 2002-03-11 | 2012-08-28 | Lab 21 Limited | Método y composiciones para identificar y caracterizar la Hepatitis C |
-
2003
- 2003-03-11 ES ES08000552T patent/ES2386742T3/es not_active Expired - Lifetime
- 2003-03-11 DK DK03714097T patent/DK1490383T3/da active
- 2003-03-11 DE DE60326327T patent/DE60326327D1/de not_active Expired - Lifetime
- 2003-03-11 AT AT08000552T patent/ATE556084T1/de active
- 2003-03-11 DE DE60332781T patent/DE60332781D1/de not_active Expired - Lifetime
- 2003-03-11 EP EP03714097A patent/EP1490383B1/de not_active Expired - Lifetime
- 2003-03-11 PT PT08014584T patent/PT2014671E/pt unknown
- 2003-03-11 EP EP08014584A patent/EP2014671B1/de not_active Expired - Lifetime
- 2003-03-11 AT AT08014584T patent/ATE469162T1/de active
- 2003-03-11 WO PCT/US2003/007585 patent/WO2003077729A2/en not_active Application Discontinuation
- 2003-03-11 EP EP08000552A patent/EP1947104B1/de not_active Expired - Lifetime
- 2003-03-11 ES ES08014584T patent/ES2346717T3/es not_active Expired - Lifetime
- 2003-03-11 DK DK08014584.0T patent/DK2014671T3/da active
- 2003-03-11 DK DK08000552.3T patent/DK1947104T3/da active
- 2003-03-11 PT PT03714097T patent/PT1490383E/pt unknown
- 2003-03-11 AT AT03714097T patent/ATE423785T1/de active
- 2003-03-11 PT PT08000552T patent/PT1947104E/pt unknown
- 2003-03-11 ES ES03714097T patent/ES2321498T3/es not_active Expired - Lifetime
- 2003-03-11 AU AU2003218111A patent/AU2003218111B8/en not_active Ceased
-
2004
- 2004-09-09 US US10/938,405 patent/US20070172926A1/en not_active Abandoned
-
2008
- 2008-07-21 US US12/176,577 patent/US8173795B2/en not_active Expired - Fee Related
- 2008-11-27 AU AU2008249300A patent/AU2008249300B2/en not_active Ceased
-
2012
- 2012-04-26 US US13/457,180 patent/US20120322051A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1490383B1 (de) | 2009-02-25 |
ES2321498T3 (es) | 2009-06-08 |
AU2003218111A1 (en) | 2003-09-29 |
DK1490383T3 (da) | 2009-06-08 |
WO2003077729A9 (en) | 2004-04-22 |
AU2008249300A1 (en) | 2008-12-18 |
PT2014671E (pt) | 2010-06-16 |
EP1490383A2 (de) | 2004-12-29 |
EP2014671A1 (de) | 2009-01-14 |
AU2003218111B2 (en) | 2008-11-06 |
US8173795B2 (en) | 2012-05-08 |
EP1947104B1 (de) | 2012-05-02 |
PT1947104E (pt) | 2012-08-09 |
ATE469162T1 (de) | 2010-06-15 |
DE60332781D1 (de) | 2010-07-08 |
DK1947104T3 (da) | 2012-08-06 |
AU2008249300B2 (en) | 2012-08-16 |
DE60326327D1 (de) | 2009-04-09 |
EP1947104A3 (de) | 2009-04-08 |
AU2003218111B8 (en) | 2008-11-20 |
EP1947104A2 (de) | 2008-07-23 |
ATE423785T1 (de) | 2009-03-15 |
EP2014671B1 (de) | 2010-05-26 |
ES2346717T3 (es) | 2010-10-19 |
WO2003077729A2 (en) | 2003-09-25 |
US20090047663A1 (en) | 2009-02-19 |
EP1490383A4 (de) | 2005-12-21 |
US20070172926A1 (en) | 2007-07-26 |
US20120322051A1 (en) | 2012-12-20 |
WO2003077729A3 (en) | 2004-06-03 |
ES2386742T3 (es) | 2012-08-28 |
DK2014671T3 (da) | 2010-09-20 |
PT1490383E (pt) | 2009-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE556084T1 (de) | Verfahren und zusammensetzungen zur identifizierung und charakterisierung von hepatitis c | |
DE60039037D1 (de) | Methode zur direkten sequenzierung von nukleinsäuren | |
ATE432365T1 (de) | Verfahren, kits und reagenzien zur nukleinsäuresequenzierung | |
DE60041940D1 (de) | Oligonukleotidprimer zur effizienten Detektion von Hepatitis C Virus (HCV) sowie Verwendungsverfahren | |
ATE364718T1 (de) | Verfahren zur vervielfältigung von nukleinsäure | |
ATE257861T1 (de) | Methoden und zusammensetzungen zur effizienten nukleinsaeuresequenzierung | |
ATE348881T1 (de) | Thermostabiles taq polymerase fragment | |
ATE542917T1 (de) | Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe | |
ATE485391T1 (de) | Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe | |
DE60132924D1 (de) | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) | |
ATE516365T1 (de) | Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer | |
DE60324819D1 (de) | Verfahren zur amplifikation von nukleinsäure, kit zur amplifikation von nukleinsäure, verfahren zum nachweis von einzelnukleotid-polymorphismus und reagentienkit zum nachweis von einzelnukleotid-polymorphismus | |
DE60024679D1 (de) | Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes | |
DE60015210D1 (de) | Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung | |
ATE486932T1 (de) | Thermostabile dna polymerase von archae ampullavirus abv und dessen verwendungen | |
DE59912683D1 (de) | Verfahren und Zusammensetzungen zur Isolierung und Reinigung von Nukleinsäuren | |
DE602004022702D1 (de) | Verfahren und kit zur abschätzung der nebenwirkung durch eine paclitaxel-therapie | |
ATE328117T1 (de) | Verfahren und sonden zur genetischen diagnose von heriditärer hämochromatose | |
ATE414175T1 (de) | Detektion von rpob sequenzen von mycobacterium tuberculosis | |
DE602006005932D1 (de) | Verfahren zur identifizierung von proteinfaltungsinhibitoren |